Our genomic findings corroborate those of prior studies that reported significant enrichment of Hippo pathway (which includes the NF2 gene) mutations19 in S vs non-S RCC tumors and BAP1 mutations in S and R RCC tumors12,15,35. Here, NF2 is linked to renal cell carcinoma.